EUVIMEDObjevte EUVIMED
Randomisierte kontrollierte StudieStudienprotokollOpen access

Cardio-Cerebral Protective Effect of Moxibustion on Phlegm-Dampness Type Hypertension: Protocol for a Randomized Controlled Trial

Ling Cheng iD, Ning Bai iD, Liang Zheng iD, Lulu Cao iD, Huangan Wu iD, Ruiping Wang iD, Chen Zhao iD, Yunli Shen iD, Haiyin Zhao iD, Gang Li iD, Bing Yang iD, Qinghui Yang iD and 7 more

JMIR Research Protocols · 2025

DOI: 10.2196/79158 ↗

At a glance

Randomisierte kontrollierte Studie in JMIR Research Protocols, 2025. Written by Ling Cheng and 18 co-authors. Institution: Acupuncture and Moxibustion Department of East Hospital Affiliated to Tongji University, Shanghai, China. Major MEDLINE topics: Moxibustion, Hypertension. 49 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Hypertension is associated with a high rate of disability and mortality and leads to a substantial socioeconomic burden. Moxibustion is an external treatment in traditional Chinese medicine that has been used to treat mild to moderate hypertension in individuals with phlegm-dampness constitution and has demonstrated acupoint specificity. However, a standard large-scale randomized controlled trial is still needed to verify its effectiveness. This study is proposed to examine the clinical effectiveness and potential cardioprotective benefits of moxibustion performed at home as a treatment for individuals with phlegm-dampness hypertension.

Objective

The objective of this trial is to evaluate the cardio-cerebral protective clinical efficacy of moxibustion for phlegm-dampness type hypertension and to explore its acupoint specific effects.

Methods

This study is a multicenter, randomized controlled trial. A total of 120 patients with mild to moderate hypertension and phlegm-dampness constitution will be recruited and randomly assigned in a 1:1 ratio to the treatment group (acupoint: Zusanli, ST36) or the control group (acupoint: Xuanzhong, GB39). All patients will receive 12 weeks of treatment and a 12-week follow-up period. The primary outcome measure is the change in morning systolic blood pressure from baseline to week 12. The secondary outcome measures include blood pressure–related indicators (morning diastolic blood pressure, average systolic blood pressure, average diastolic blood pressure, nighttime systolic blood pressure, nighttime diastolic blood pressure, and blood pressure circadian rhythm) and short-term blood pressure variability coefficient, all of which will be measured by 24-hour ambulatory blood pressure monitoring. Additionally, cardiac-related indicators measured by 24-hour Holter monitoring, metabolic disorder-related indicators, liver and kidney function indicators, transformed scores of the traditional Chinese medicine phlegm-dampness constitution scale, and the Montreal Cognitive Assessment will also be evaluated.

Results

This study was registered on July 5, 2024, with the Chinese Clinical Trial Registry. Data collection began in June 2023 and ended in February 2025. Currently, data from this trial are in the collection phase, and no data analysis has been performed. As of January 2025, we have collected data from 118 patients. The results of this trial are expected to be submitted for publication in May 2026.

Conclusions

This multicenter, randomized, controlled clinical trial will provide evidence on the clinical effectiveness and potential cardioprotective benefits of moxibustion performed at home as a treatment for individuals with phlegm-dampness type of hypertension. Trial Registration Chinese Clinical Trial Registry ChiCTR2400086582; https://www.chictr.org.cn/showproj.html?proj=211688 International Registered Report Identifier (IRRID) DERR1-10.2196/79158

Subjects

MeSH terms (MEDLINE)

MoxibustionHypertensionHumansFemaleMaleMiddle AgedAdultBlood PressureRandomized Controlled Trials as TopicAcupuncture PointsTreatment OutcomeAgedMulticenter Studies as TopicMedicine, Chinese Traditional

Author keywords

acupoint specificityblood pressurecardioprotectionhypertensionmoxibustionpatientstreatmenttrials

Authors and institutions

  • Acupuncture and Moxibustion Department of East Hospital Affiliated to Tongji University, Shanghai, China.
  • Shanghai Jinshan Traditional Chinese Medicine-Integrated Hospital, Shanghai, China.
  • State Key Laboratory of Cardiovascular Diseases and Medical Innovation Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Shanghai Research Institute of Acupuncture and Meridian, Shanghai, China.
  • Shanghai Skin Disease Hospital, Medical School, Tongji University, Shanghai, China.
  • Shanghai University of Traditional Chinese Medicine, Shanghai, China.

ORCID profiles: Ling Cheng, Ning Bai, Liang Zheng, Lulu Cao, Huangan Wu, Ruiping Wang, Chen Zhao, Yunli Shen, Haiyin Zhao, Gang Li, Bing Yang, Qinghui Yang, Yan Xing, Jianhong Cao, Yixing Wang, Ling Xu, Junjie Yan, Jie Cao, Yiyang Guo

Cite

APA

Cheng, L., Bai, N., Zheng, L., Cao, L., Wu, H., Wang, R., Zhao, C., Shen, Y., Zhao, H., Li, G., Yang, B., Yang, Q., Xing, Y., Cao, J., Wang, Y., Xu, L., Yan, J., Cao, J., & Guo, Y. (2025). Cardio-Cerebral Protective Effect of Moxibustion on Phlegm-Dampness Type Hypertension: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/79158

Vancouver

Cheng L, Bai N, Zheng L, Cao L, Wu H, Wang R, et al. Cardio-Cerebral Protective Effect of Moxibustion on Phlegm-Dampness Type Hypertension: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 2025. doi:10.2196/79158

BibTeX
@article{Cheng2025,
  author = {Cheng, Ling and Bai, Ning and Zheng, Liang and Cao, Lulu and Wu, Huangan and Wang, Ruiping and Zhao, Chen and Shen, Yunli and Zhao, Haiyin and Li, Gang and Yang, Bing and Yang, Qinghui and Xing, Yan and Cao, Jianhong and Wang, Yixing and Xu, Ling and Yan, Junjie and Cao, Jie and Guo, Yiyang},
  title = {Cardio-Cerebral Protective Effect of Moxibustion on Phlegm-Dampness Type Hypertension: Protocol for a Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2025},
  doi = {10.2196/79158}
}
Start for free →